Online Pharmacy Urges FDA to Pull All Ranitidine Products

Drug Industry Daily
An online pharmacy petitioned the FDA to recall and suspend the sale of all ranitidine-containing products in the U.S., raising alarms after its tests of the drug detected high levels of NDMA impurities across multiple manufacturers and dosage forms.

To View This Article:


Subscribe To Drug Industry Daily